Zenas BioPharma, Inc. , a clinical-stage biopharmaceutical company, engages in the development and commercialization of transformative immunology-based therapies.
Zenas Biopharma stock last closed at $7.71, down 1.78% from the previous day, and has decreased N/A in one year. It has underperformed other stocks in the Biotechnology industry by N/A percentage points. Zenas Biopharma stock is currently +32.25% from its 52-week low of $5.83, and -70.63% from its 52-week high of $26.25.
At the moment, there are 41.79M ZBIO shares outstanding. The market capitalization of ZBIO is $322.21M. In the past 24 hours, 209,196 ZBIO shares were traded.
How to Buy Zenas Biopharma Stock
Wondering how to invest in Zenas Biopharma stock? Here's how.
Choose where to buy Zenas Biopharma stock: You need to decide on an online brokerage, but don't worry - we've sifted through dozens of online brokerages and apps to help you determine where to buy Zenas Biopharma stock.
Create a brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've found.
Deposit funds into your investment account: Choose your payment method and add your details.
Research Zenas Biopharma stock: The Zenas Biopharma ticker symbol is ZBIO. Is Zenas Biopharma stock a good investment? Should you buy shares of ZBIO? How do ZBIO's underlying business fundamentals look? Do top analysts think Zenas Biopharma is a good buy? Why has ZBIO's stock price moved recently? (Hint: Our stock market research tools can help you evaluate if ZBIO is a good stock to buy).
Execute your ZBIO trade: Decide if you will purchase ZBIO shares at the current market price or use a limit order to buy ZBIO shares at a specific price.
Get key alerts regarding your ZBIO position: Create a watchlist to key updates about your new investment in Zenas Biopharma stock.
Step 1: Choose where to buy Zenas Biopharma stock
You will need a brokerage account to access the NASDAQ market and buy ZBIO stock.
A brokerage account allows you to buy and sell a number of financial instruments, such as stocks, bonds, mutual funds, and ETFs.
Our preferred brokerage: eToro
In our opinion, eToro is the best place to buy stocks. Here's why:
Invest in stocks with zero commissions: Invest without paying trading commissions.
Buy fractional shares: Even if you don't have the money to buy a full share, you can still invest in the stock.
Access to world markets: From Tech to Industrials, New York to Tokyo — you can fill your portfolio with stocks from the globe's leading exchanges.
Social investing: eToro offers a community with more than 20 million users around the world. Talk to, learn from, and copy the crypto trades of other investors.
Security: eToro is a regulated and licensed fintech leader.
Buy other financial assets: Such as ETFs and cryptocurrencies.
Get $10 towards your purchase of stock by signing up for an account with eToro now.
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.
Step 2: Create a brokerage account
Now that you've selected the best brokerage, it's time to fill out some personal info so you are able to buy ZBIO today.
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
Step 4: Research Zenas Biopharma stock
Once you have figured out the best place to buy Zenas Biopharma stock, it's critical to research their stock before you invest, so you actually comprehend the risk as well as the upside.
Zenas Biopharma Numbers
ZBIO Price
$7.71
1w %
-3.87%
1y %
N/A
5y %
N/A
P/E
N/A
P/B
0.9x
P/S
N/A
PEG
N/A
Revenue
N/A
Earnings
N/A
Fore. Rev. Growth
N/A
Fore. Earn. Growth
N/A
Market Cap
$322.21M
Next Earnings
N/A
Next Dividend
N/A
Zenas Biopharma Due Diligence Checks
WallStreetZen was designed to help everyday investors do better fundamental analysis in minutes instead of hours.
There are more short-term assets than long-term liabilities on the ZBIO balance sheet.
There are more short-term assets than short-term liabilities on the ZBIO balance sheet.
ZBIO has a low debt to equity ratio of 0.12.
Is it a good time to buy ZBIO stock, according to Wall Street analysts?
Out of 6 Equities analysts who give recommendations on ZBIO, the consensus analyst rating on ZBIO is a Strong Buy
It's important to note that analyst forecasts are not stock recommendations, nor are they financial advice.
Latest ZBIO Analyst Upgrades/Downgrades
Yatin Suneja, a bottom 15% analyst from Guggenheim initiates coverage on ZBIO with a strong buy rating and announces their ZBIO price target of $45.00, on Oct 8, 2024.
No, Zenas Biopharma doesn't provide an income stream by paying out dividends.
Get opinions from other traders
One of the primary reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to learn what other traders have to say.
Step 5: Execute your ZBIO trade
There are two main types of orders:
Market order: A market order is an order to buy or sell a security at the best price on the market. Market orders are mostly the best for newer investors.
Limit order: A limit order lets you buy or sell a stock at a specific price (or better). If you want to be sure you're buying or selling at a given price, use a limit order.
Press the Open button and your broker will place the order.
If you need additional assistance investing in stocks on eToro, watch the helpful video below:
How much does it cost to buy one Zenas Biopharma share?
As of Feb 7, 2025, it costs $7.71 to buy one share of Zenas Biopharma stock.
Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $3, you can buy 0.389 shares of ZBIO.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.